According to Fox News’ Peter Johnson Jr., Chimerix has given hundreds of patients emergency access to Brincidofovir in the past, but Moch said the company has since stopped this practice because “they cannot afford it.”
The drug is currently in Phase 3 trials and has been tested on 150 pediatric patients. I can’t speak to their “giving away” product that has not yet been approved unless they did something in Phase 2. The drug looks promising but the data that will go to the FDA for submission isn’t expected until 2015. If the FDA accelerates the application it may take 12 to 18 months for approval after that submission. So, the drug is not approved and their attorney best have one hell of a legal agreement absolving the company of any liability if this child should not make it.